Ping Meng
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Nephrology top 5%
- Acute Kidney Injury Research
- Chronic Kidney Disease and Diabetes
Papers in
- Nephrology 12
- Acute Kidney Injury Research 7
- Chronic Kidney Disease and Diabetes 6
-
- Mitochondrial Function and Pathology 4
- Peroxisome Proliferator-Activated Receptors 3
- Co-authors
- Lili Zhou (11 shared papers)Weijun Qin (6 shared papers)Fuli Wang (12 shared papers)Yunfang Zhang (11 shared papers)Feng Xiao (1 shared paper)Xiaoping Pan (1 shared paper)Sumei Li (1 shared paper)Jianlin Yuan (3 shared papers)
In The Last Decade
Ping Meng
49 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 83
- Cancer Research 209
- Nephrology 145
- Aging 13
- Molecular Biology 282
- Pharmaceutical Science 30
Countries citing papers authored by Ping Meng
This map shows the geographic impact of Ping Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Meng more than expected).
Fields of papers citing papers by Ping Meng
This network shows the impact of papers produced by Ping Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Meng. The network helps show where Ping Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Ping Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 213 | |
| 2 | 2021 | 132 | |
| 3 | 2020 | 54 | |
| 4 | 2017 | 49 | |
| 5 | 2019 | 48 | |
| 6 | 2018 | 47 | |
| 7 | 2022 | 42 | |
| 8 | 2009 | 41 | |
| 9 | 2022 | 33 | |
| 10 | 2018 | 31 | |
| 11 | 2020 | 31 | |
| 12 | 2020 | 29 | |
| 13 | 2019 | 28 | |
| 14 | 2021 | 25 | |
| 15 | 2020 | 24 | |
| 16 | 2020 | 22 | |
| 17 | 2018 | 20 | |
| 18 | 2022 | 20 | |
| 19 | 2025 | 20 | |
| 20 | 2018 | 17 |
About Ping Meng
Ping Meng is a scholar working on Nephrology, Molecular Biology, Psychiatry and Mental health, Cell Biology and Pulmonary and Respiratory Medicine, having authored 49 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Kidney Injury Research (7 papers), Chronic Kidney Disease and Diabetes (6 papers), Sexual function and dysfunction studies (5 papers), Mitochondrial Function and Pathology (4 papers), Autophagy in Disease and Therapy (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Chemokine receptors and signaling (2 papers). The work is most often cited by research in Cancer Research (209 citations), Nephrology (145 citations), Aging (13 citations), Molecular Biology (282 citations) and Pharmaceutical Science (30 citations). Ping Meng has collaborated with scholars based in China, Grenada and Italy. Frequent co-authors include Lili Zhou, Weijun Qin, Fuli Wang, Yunfang Zhang, Feng Xiao, Xiaoping Pan, Sumei Li, Jianlin Yuan, Xian Ling and Mingsheng Zhu. Their work appears in journals such as Frontiers in Oncology, Cell Death and Disease, Scientific Reports, Frontiers in Cell and Developmental Biology and The Journal of Sexual Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.